CLOSE X

RK Global

MISSED CALL NO 7412074708
Search
Company Profile
more from company profile
HomeMarkets Company Profile Quarterly Results

Quarterly Results

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE7890.95114.85 (+1.48 %)
PREV CLOSE ( ) 7776.10
OPEN PRICE ( ) 7999.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 376
TODAY'S LOW / HIGH ( )7849.95 8150.00
52 WK LOW / HIGH ( )7630 10653.05
NSE7889.5098 (+1.26 %)
PREV CLOSE( ) 7791.50
OPEN PRICE ( ) 8000.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7111
TODAY'S LOW / HIGH( ) 7843.00 8000.00
52 WK LOW / HIGH ( )7551.5 10691
GO
(Rs.in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
6115.70
5590.90
5263.10
4804.80
Total Expenditure
5667.40
4839.10
4452.00
3941.10
PBIDT (Excl OI)
448.30
751.80
811.10
863.70
Other Income
51.30
61.70
112.40
161.50
Operating Profit
499.60
813.50
923.50
1025.20
Interest
10.60
6.70
7.20
6.80
Exceptional Items
14.80
-52.90
-3.60
-56.80
PBDT
503.80
753.90
912.70
961.60
Depreciation
38.40
25.70
165.70
176.90
Profit Before Tax
465.40
728.20
747.00
784.70
Tax
139.50
186.00
188.70
202.20
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
325.90
542.20
558.30
582.50
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
325.90
542.20
558.30
582.50
Equity Capital
50.00
50.00
50.00
50.00
Face Value (IN RS)
2
2
2
2
Reserves
Calculated EPS
13.04
21.69
22.33
23.30
Calculated EPS (Annualised)
52.14
86.75
89.33
93.20
No of Public Share Holdings
6250000.00
6250000.00
6250000.00
6250000.00
% of Public Share Holdings
25.00
25.00
25.00
25.00
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
7.33
13.45
15.41
17.98
PBIDTM%
8.17
14.55
17.55
21.34
PBDTM%
8.24
13.48
17.34
20.01
PBTM%
7.61
13.02
14.19
16.33
PATM%
5.33
9.70
10.61
12.12
 
Notes
Notes
Notes
Notes
Call Us +91 -33 40142930
Email Us care.kolkata@rkglobal.in
Corporate Office Flat No.5 Sagar Apartment 6 Tilak Marg, New Delhi 110 001
Attention Investors

Prevent unauthorised Transactions in your account —> Update your mobile numbers/email 10s with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...... Issued in the interest of Investors Prevent Unauthorized Transactions in your demat account—> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day Issued in the interest of investors. No need to issue cheques by investor while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of

KYC

KYC KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DR Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Compliance Officer : Mr. Kamesh Gupta. 011-43100999. kgupta@rkglobal.in / grievances@rkglobal.in - File a Complaint on SCORES

Registration Nos : SEBI Registration No . INZ000187132; Research Regn. No. : INH000002210; IN-DP-241-2016; NSDL: DP ID - IN 302453 (Delhi), IN 302951 (Kolkata); R K Global Shares & Securities Ltd CIN NO:U99999MH1995PTC174185;

Filing Complaints on SCORES - Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID. Benefits: Effective Communication, Speedy redressal of the grievances.

Company
Quick LInks

Copyrights 2020 © rkglobal.in - All Right Reserved

Designed,Developed & Content Powered by Accord Fintech Pvt Ltd.